Anthony Geraci, MD
Neurology · Great Neck, NYNPI 1871511238
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $195,651 of the $278,750 with a category attached, or 70.2%. Biogen accounts for 66.9% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $103,448 and has fallen 100.0% since, to $15 in 2025. Among neurology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 202 payments — averaging $1379.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$186K
- AstraZeneca$60K
- Catalyst Pharmaceuticals, Inc.$12K
- Alnylam Pharmaceuticals Inc.$12K
- Genentech, Inc.$8K
- AbbVie$162
- plus $57 from 3 others
Across 40 payments — averaging $11,878 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$169K
- UCB SA$151K
- AstraZeneca$120K
- Amgen$33K
- UCB Biosciences Inc.$1K
What the payments were for
- Consulting fees$68,52825%
- Speaking & faculty fees$195,65170%
- Travel & lodging$10,5304%
- Food & beverage$4,0261%
- Education$150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 110 | $186,407 |
| AstraZeneca | 62 | $60,316 |
| Catalyst Pharmaceuticals, Inc. | 7 | $11,998 |
| Alnylam Pharmaceuticals Inc. | 7 | $11,854 |
| Genentech, Inc. | 4 | $7,955 |
| AbbVie | 9 | $162 |
| SS White Burs LLC | 1 | $30 |
| UCB, Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPINRAZA$170,061
- SOLIRIS$56,438
- FIRDAPSE$11,825
- Non-Covered Product$7,955
- ONPATTRO$5,547
How this compares
$278,750 in reported general payments places this provider in the 95th percentile of 1,623 neurology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Great Neck
- Noah RosenGreat Neck$272K
- Robert DuarteGreat Neck$250K
- Idan SharonBrooklyn$2.1M
- Allan PerelStaten Island$1.7M
- Nicolas SaikaliAmherst$1.5M
- David KreitzmanCommack$1.5M
- Charles ArgoffAlbany$1.2M
- Stephen KriegerNew York$1.1M
- Robert FeketeHawthorne$1M
- Jennifer McVigeAmherst$982K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.